BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23027846)

  • 1. On the value of portfolio diversity in heart, lung, and blood research.
    Galis ZS; Hoots WK; Kiley JP; Lauer MS
    Am J Respir Crit Care Med; 2012 Oct; 186(7):575-8. PubMed ID: 23027846
    [No Abstract]   [Full Text] [Related]  

  • 2. The Extramural Division of Cardiovascular Sciences of the National Heart, Lung, and Blood Institute.
    Lauer MS; Skarlatos SI; Bild DE
    J Am Coll Cardiol; 2009 Jul; 54(3):265-8. PubMed ID: 19589441
    [No Abstract]   [Full Text] [Related]  

  • 3. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
    Shurin SB
    Blood; 2011 Nov; 118(20):5380-2. PubMed ID: 21868577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025.
    Mensah GA; Kiley J; Mockrin SC; Lauer M; Hoots WK; Patel Y; Cook NL; Patterson AP; Gibbons GH
    Am J Public Health; 2015 May; 105(5):e25-8. PubMed ID: 25723452
    [No Abstract]   [Full Text] [Related]  

  • 5. What if . . . the National Heart, Lung, and Blood Institute Considers Tobacco?
    Soriano JB; Morera J
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1471. PubMed ID: 26075430
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply: "What if . . . the National Heart, Lung, and Blood Institute Considers Tobacco?" and "Smoking Control Is a Priority to Promote Heart, Lung, Blood, and Sleep Health".
    Kiley J; Mockrin S; Lauer M; Mensah G; Hoots WK; Patel Y; Cook N; Patterson A; Gibbons G
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1473. PubMed ID: 26075432
    [No Abstract]   [Full Text] [Related]  

  • 7. National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.
    Mulligan MS; Weill D; Davis RD; Christie JD; Farjah F; Singer JP; Hartwig M; Sanchez PG; Kreisel D; Ware LB; Bermudez C; Hachem RR; Weyant MJ; Gries C; Awori Hayanga JW; Griffith BP; Snyder LD; Odim J; Craig JM; Aggarwal NR; Reineck LA
    J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2355-2365. PubMed ID: 30244865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025.
    Kiley J; Mockrin S; Lauer M; Mensah GA; Hoots K; Patel Y; Cook NL; Patterson AP; Gibbons GH
    Am J Respir Crit Care Med; 2015 Mar; 191(5):489-91. PubMed ID: 25706106
    [No Abstract]   [Full Text] [Related]  

  • 9. Smoking Control Is a Priority to Promote Heart, Lung, Blood, and Sleep Health.
    Jimenez-Ruiz CA; Sculier JP; Lundback B; Vardavas C; Ignacio De Granda Orive J; Katsaounou P; Haslam P; Heederik DJ; Ravara S; Smyth D; Martin F; Gratziou C;
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1471-3. PubMed ID: 26075431
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis Research: Extramural Portfolio Supported by the National Heart, Lung, and Blood Institute, 2008-2015.
    Gao Y; Stanley DV; Robinson VC; Reid DM; Galis ZS
    Circ Res; 2017 May; 120(11):1713-1717. PubMed ID: 28546354
    [No Abstract]   [Full Text] [Related]  

  • 11. ARDS Network (NHLBI) studies: successes and challenges in ARDS clinical research.
    Thompson BT; Bernard GR
    Crit Care Clin; 2011 Jul; 27(3):459-68. PubMed ID: 21742211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness research: welcome to the real world.
    Klein HG
    Transfusion; 2012 Jun; 52(6):1162-4. PubMed ID: 22686529
    [No Abstract]   [Full Text] [Related]  

  • 13. Shaping the future of research: the NHLBI strategic plan.
    Nabel EG
    Blood; 2007 Dec; 110(13):4143. PubMed ID: 18056844
    [No Abstract]   [Full Text] [Related]  

  • 14. On the value of portfolio diversity in heart, lung, and blood research.
    Galis ZS; Hoots WK; Kiley JP; Lauer MS
    Blood; 2012 Sep; 120(12):2361-4. PubMed ID: 22923497
    [No Abstract]   [Full Text] [Related]  

  • 15. Notes from the NHLBI director: transitions.
    Nabel EG
    Am J Respir Crit Care Med; 2009 Feb; 179(4):263-4. PubMed ID: 19201927
    [No Abstract]   [Full Text] [Related]  

  • 16. On the value of portfolio diversity in heart, lung, and blood research.
    Galis ZS; Hoots WK; Kiley JP; Lauer MS
    Circ Res; 2012 Sep; 111(7):833-6. PubMed ID: 22891047
    [No Abstract]   [Full Text] [Related]  

  • 17. How the National Heart, Lung, and Blood Institute (NHLBI) develops research priorities and supports critical care research.
    Harabin AL; Kiley JP
    Phys Ther; 2012 Dec; 92(12):1489-93. PubMed ID: 22836006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology research support at the National Heart, Lung, and Blood Institute.
    Buxton DB
    Circ Res; 2011 Jul; 109(3):250-4. PubMed ID: 21778434
    [No Abstract]   [Full Text] [Related]  

  • 19. Notes from the NHLBI director: shaping the future of research--the NHLBI strategic plan.
    Nabel EG
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1178. PubMed ID: 18057424
    [No Abstract]   [Full Text] [Related]  

  • 20. How one program at the National Heart, Lung, and Blood Institute establishes its scientific priorities.
    Bild DE; Lauer MS
    J Am Coll Cardiol; 2009 Jun; 53(24):2259-61. PubMed ID: 19520248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.